Outset Medical (OM) Raw Materials (2019 - 2026)

Outset Medical (OM) has 8 years of Raw Materials data on file, last reported at $29.9 million in Q1 2026.

• Quarterly Raw Materials rose 19.66% year-over-year to $29.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.9 million (up 19.66% YoY) and the FY2025 annual result came in at $27.2 million, up 5.76% from the prior year.
• Raw Materials grew to $29.9 million in Q1 2026 per OM's latest filing, from $27.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $29.9 million in Q1 2026 and bottomed at $16.0 million in Q1 2022.
• The 5-year median for Raw Materials is $22.3 million (2024), against an average of $23.0 million.
• The widest annual swing landed in 2022, when Raw Materials surged 54.15%; it then dropped 9.3% in 2023.
• Tracing OM's Raw Materials over 5 years: stood at $20.6 million in 2022, then fell by 9.3% to $18.7 million in 2023, then soared by 37.41% to $25.7 million in 2024, then gained by 5.76% to $27.2 million in 2025, then grew by 9.91% to $29.9 million in 2026.
• Per Business Quant, the three latest OM Raw Materials figures stand at $29.9 million (Q1 2026), $27.2 million (Q4 2025), and $26.0 million (Q3 2025).

Peer Comparison